Analysts Eye FUNToken’s Giveaway as the Push It Needed to Break Out
After months of steady consolidation, FUNToken ($FUN) is once again drawing attention from market analysts watching for the next potential breakout. Currently
After months of steady consolidation, FUNToken ($FUN) is once again drawing attention from market analysts watching for the next potential breakout. Currently
Transak, a leading Web3 payments infrastructure provider and the official fiat-onramp partner of MetaMask, has secured six new Money Transmitter Licenses (MTLs)
The U.S. Government shutdown may finally be nearing its conclusion amid fresh developments. The House Rules Committee has approved a Senate-passed funding
Top altcoins Cardano (ADA), Solana (SOL), and Ethereum (ETH) continue to slump today. The US dollar wavers as traders mull a December Fed
Visa has launched a new pilot program that will let the company’s U.S. clients and businesses send and receive payments directly in
Chainlink price is showing a bullish trend, currently holding above the $15 level after a period of consolidation. The price has risen
Back in 2017, ICOs raised over $5.6 billion, turning crypto fundraising into one of the biggest financial experiments of the decade. It
As COP30 convenes in Belém, Brazil, the global urgency to tackle climate change feels sharper than ever. Meeting ambitious sustainability goals requires
Corazon Mining (CZN:AU) has announced Two Pools Gold Project update Download the PDF here. This post appeared first on investingnews.com
As humanity edges closer to mining the moon, industry analysts warn that established mining companies, not venture-backed space startups, may dominate the
Sound money advocate and author Larry Lepard shares his thoughts on what’s driving gold, silver and Bitcoin prices, as well as how
Mark Skousen of Forecasts & Strategies shares his outlook for gold, silver and the US economy. ‘We’ve entered an era of what
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division —